Medical Mutual Insurance Company of Maine

Frequently Asked Questions related to risk management.

Risk Management » Practice Tips

July 2009

CLIA (Clinical Laboratory Improvement Amendments) - Federal Regulation

The Clinical Laboratory Improvement Amendments (CLIA) has established quality standards for all laboratory testing to ensure the accuracy, reliability and timeliness of patient test results regardless of where the test is performed. Under CLIA, a laboratory is defined as a facility that performs testing on human specimens for the purpose of providing information for diagnosis, prevention, treatment of disease or health assessment. Facilities, including physician office practices, that meet this definition must apply and obtain a certificate from the CLIA program to operate legally.

The CLIA regulations place tests in three categories based on the complexity of each test. The more complicated the test, the more stringent the applicable federal requirements. The categories are as follows:

Facilities performing moderate (excluding PPM) and/or high complexity testing must apply for a Certificate of Compliance (COC) or Certificate of Accreditation (COA). The COC is issued when an inspection, conducted by the appropriate State authority, determines that the laboratory is compliant with all applicable CLIA requirements. Alternatively, a COA is issued when a CMS approved accreditation organization determines the laboratory’s compliance with accreditation standards. Each facility must first apply for a Certificate of Registration to allow it to perform moderate and/or high complexity tests pending a certification inspection. If a facility wishes to add testing of a higher complexity not covered under their current certificate, it must re-apply for the appropriate certificate. Waived tests can be performed with any certificate.

Certification for all waived and non-waived testing is issued on a two-year basis.
CMS is responsible for implementation of CLIA, including registration, fee collection, surveys and enforcement. The Centers for Disease Control and Prevention (CDC) provides scientific and technical support and consultation to CMS. The Food and Drug Administration (FDA) is responsible for test categorization.

The CMS survey process is outcome oriented, focusing on quality and education as the best tools to assess compliance. Available data indicates that CLIA has contributed to an improved quality of testing in the United States. Further information about CLIA can be accessed at www.cms.hhs.gov/clia or by contacting your local state survey agency. The agencies for Maine, New Hampshire and Vermont are listed below.

Maine

CLIA Program
Division of Licensing & Regulatory Services
41 Anthony Avenue, Station #11
Augusta, Maine 04330-0011
207-287-9339
Fax: 207-287-9304
Contact: Margaret Naas

New Hampshire

Health Facilities Administration
Department of Health & Human Services
129 Pleasant Street
Concord, NH 03301
603- 271- 4832
Fax: 603-271-4968
Contact: Rodney Bascom

Vermont
CLIA Laboratory Program
Vermont Department of Health
108 Cherry Street
Burlington, VT 05401
802- 652- 4145
Fax: 802-865-7701
Contact: Carol Drawbaugh


Medical Mutual's "Practice Tips" are offered as reference information only and are not intended to establish practice standards or serve as legal advice. MMIC recommends you obtain a legal opinion from a qualified attorney for any specific application to your practice.